YAKHAK HOEJI
ISSN 0377-9556 (PRINT)
ISSN 2383-9457 (ONLINE)
ISSN 2383-9457 (ONLINE)
The number of adverse events of tocilizumab
All adverse events | |
---|---|
number (%) | |
Skin and appendages disorders | 98 (25.9) |
Rash | 34 (9.0) |
Pruritus | 30 (7.9) |
Urticaria | 17 (4.5) |
Rash erythematous | 5 (1.3) |
Alopecia | 4 (1.1) |
Body as a whole-general disorders | 55 (14.5) |
Anaphylactic reaction | 11 (2.9) |
Chest pain | 10 (2.6) |
Fever | 7 (1.8) |
Rigors | 4 (1.1) |
Respiratory system disorders | 40 (10.6) |
Dyspnoea | 13 (3.4) |
Pharyngitis | 6 (1.6) |
Pneumonia | 6 (1.6) |
Coughing | 5 (1.3) |
Upper respiratory tract infection | 4 (1.1) |
Liver and biliary system disorders | 36 (9.5) |
Hepatic enzymes increased | 23 (6.1) |
SGPT increased | 4 (1.1) |
SGOT increased | 4 (1.1) |
White cell and RES* disorders | 28 (7.4) |
Leucopenia | 18 (4.7) |
Granulocytopenia | 7 (1.8) |
Gastro-intestinal system disorders | 28 (7.4) |
Nausea | 11 (2.9) |
Vomiting | 7 (1.8) |
Abdominal pain | 6 (1.6) |
Central & peripheral nervous system disorders | 20 (5.3) |
Dizziness | 6 (1.6) |
Paraesthesia | 6 (1.6) |